89. Lymphangioleiomyomatosis Clinical trials / Disease details

Clinical trials : 39 / Drugs : 46 - (DrugBank : 20) / Drug target genes : 27 - Drug target pathways : 137

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00005906 (ClinicalTrials.gov)	June 2000	9/6/2000	Treatment With Octreotide in Patients With Lymphangioleiomyomatosis	Treatment With Octreotide in Patients With Lymphangioleiomyomatosis	Lymphangioleiomyomatosis;Lymphangiomyomas;Pleural Effusions;Ascites	Drug: Octreotide	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Completed	18 Years	65 Years	Female	4	Phase 2	United States